https://www.selleckchem.com/pr....oducts/Sunitinib-Mal
The results of molecular docking and ADME/T studies have revealed 6 constituents as potential drug candidates that can inhibit the binding of SARS-CoV-2 spike protein with the human receptor ACE2 protein. The narrowed down list of constituents from Tinospora cordifolia paved way for further tuning their ability to inhibit COVID-19 by modifying the chemical structures and by employing computational geometry optimization and docking methods. The online version contains supplementary material available at 10.1007/s13337-0
Like
Comment
Share
